|
ZOOM LINK: https://iaedp.zoom.us/j/83846759068 Binge Eating Disorder is a mental illness characterized by recurrent
binge eating episodes in the absence of appropriate compensatory
behaviors. It results from poor coping with negative affect, mood
dysregulation and distress intolerance. Patients use food as an escape
plan to redirect their attention from the stressor and for reinforced
reduction of stress. BED is linked to obesity, low self-esteem, guilt
and depression with high risk of suicide and various physical
complications such as DM, hypertension, cardiac problems and
cerebrovascular strokes. Detailed assessment of the neurobiological risk
factors and addressing the psychopathological implications of BED are
necessary to mitigate its negative consequences and morbidities.
Different therapeutic modalities are implemented for improving the
relation between the patient and food including E-CBT for eating
disorders, Interpersonal Psychotherapy, and Dialectical Behavioral
Therapy. Serotonergic antidepressants have an effective role in
targeting impulsivity/compulsivity related to binge episodes, modulating
both emotional reactivity and reward processing. Also we will discuss ,
the Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a new
group of drugs that were originally developed to treat type 2 diabetes
and that are increasingly prescribed to manage weight. GLP-1 RAs have
been shown to be very effective at lowering blood sugar levels. However,
there is a lack of evidence to inform whether GLP-1 RAs could be
administered in populations with Binge eating disorders . In this
webinar Dr. Essawy will provide an overview of how GLP-1RAs act in the
brain to increase feeling of satiety as well as reduce hedonic aspects
of eating behaviour such as craving. She will also cover what is known
about the role of GLP-1 in stress and mood. For Questions contact Dr. Essawy: essawi_h@yahoo.com Click to Join here Bio Heba Essawy MD, clinical Professor of Psychiatry, Ain Shams
University Hospital, Cairo, Egypt. She has been the Medical Director of
eating disorders clinics since 2013. For 28 years at the Institute of
Psychiatry she has practiced writing, lecturing, supervising and
directing outpatient eating disorders clinics. She obtained her CEDS designation from iaedp™ in 2019 and became the
first eating disorders certified specialist in Egypt. She is the Founder
and President of First Egyptian Association for Eating Disorders. Her
role has expanded treatment services to include pediatric, adolescents
and adult populations. Heba is passionate about empowering and educating
parents as well as their children. She maintains a private practice in
psychotherapy and medication management in Cairo. Heba has presented extensively, nationally and international
conferences as well as provides campus-wide training. She has been
published in academic journals and the popular media as well as
contributing chapters to several books and appeared on a variety of
local and national news and radio outlets. Special Educational Partnership since October 2021 Heba Essawy, MD, CEDS and her organization, First Egyptian
Association for Eating Disorders, are a Designated Educational Affiliate
for iaedp™ to assist individuals in Egypt in attaining the status of
Associate Designee, iaedp™ Institute on Eating Disorders. www.Hebaessawy.com
|
Print Page